Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the #construction of a new site in Menges, Slovenia. The state-of-the-art GMP #manufacturing site will significantly expand Porton’s #network beyond China and the US as it sets out to provide #solutions to customers and partners in #europe.

Moreover, Porton also started production in its Drug Product CDMOo and cell and genetherapy CDMO commercialization facilities. It also began implementing the APS (Advanced Planning and Scheduling) to boost the #efficiency in production scheduling and order fulfillment and promote #transparency in capacity planning #management.

All these production and operation efforts are part of Porton’s commitment to providing high-quality services.